In breast cancer, VRK1 depletion inhibits tumor growth and metastasis [17] and confers resistance to DNA-damaging agents [18], and it has been suggested that VRK1 is a potential therapeutic target and a prognostic marker for breast cancer [19, 20]. This evidence concerns the gene VRK1 and neoplasm.